Literature DB >> 28972293

Evaluating Burning Mouth Syndrome as a Comorbidity of Atypical Odontalgia: The Impact on Pain Experiences.

Trang T H Tu1, Anna Miura1, Yukiko Shinohara1, Lou Mikuzuki1, Kaoru Kawasaki1, Shiori Sugawara1, Takayuki Suga1, Takeshi Watanabe1, Motoko Watanabe2, Yojiro Umezaki3, Tatsuya Yoshikawa1, Haruhiko Motomura1, Miho Takenoshita1, Akira Toyofuku1.   

Abstract

OBJECTIVE: This study aimed (1) to investigate the differences in clinical characteristics of patients between 2 groups, those who have atypical odontalgia (AO) only and those who have AO with burning mouth syndrome (BMS), and (2) to assess the influence of psychiatric comorbidity factors on patients' experiences.
METHOD: Medical records and psychiatric referral forms of patients visiting the Psychosomatic Dentistry Clinic of Tokyo Medical and Dental University between 2013 and 2016 were reviewed. The final sample included 2 groups of 355 patients: those who have AO only (n = 272) and those who have AO with BMS (AO-BMS; n = 83). Clinicodemographic variables (gender, age, comorbid psychiatric disorders, and history of headache or sleep disturbances) and pain variables (duration of illness, pain intensity, and severity of accompanying depression) were collected. Initial pain assessment was done using the Short-Form McGill Pain Questionnaire, and depressive state was determined using the Zung Self-Rating Depression Scale.
RESULTS: The average age, female ratio, and sleep disturbance prevalence in the AO-only group were significantly lower than those in AO-BMS group. AO-BMS patients rated overall pain score and present pain intensity significantly higher than did the AO-only patients (P = 0.033 and P = 0.034, respectively), emphasizing sharp (P = 0.049), hot-burning (P = 0.000), and splitting (P = 0.003) characteristics of pain. Patients having comorbid psychiatric disorders had a higher proportion of sleep disturbance in both groups and a higher proportion of depressive state in the AO-only group.
CONCLUSIONS: AO-BMS patients have different epidemiological characteristics, sleep quality, and pain experiences compared to AO-only patients. The presence of psychiatric comorbidities in both groups may exacerbate sleep quality. We suggest that BMS as a comorbid oral disorder in AO patients contributes to a more intensively painful experience.
© 2017 The Authors. Pain Practice published by Wiley Periodicals, Inc. on behalf of World Institute of Pain.

Entities:  

Keywords:  atypical odontalgia; burning mouth syndrome; pain characteristic; psychiatric comorbidity; sleep disturbance

Mesh:

Year:  2017        PMID: 28972293     DOI: 10.1111/papr.12647

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  4 in total

1.  Challenges of Misdiagnosis and Suboptimal Treatment of Persistent Idiopathic Facial Pain and Atypical Odontalgia: A Retrospective Multi-Centric Cross-Sectional Investigation.

Authors:  Xiong Xiao; Lei Jiang; Longjun Liu; Guoliang Chai; Fang Luo
Journal:  J Pain Res       Date:  2020-11-10       Impact factor: 3.133

Review 2.  Persistent dentoalveolar pain disorder: A putative intraoral chronic overlapping pain condition.

Authors:  Alberto Herrero Babiloni; Donald R Nixdorf; Estephan J Moana-Filho
Journal:  Oral Dis       Date:  2019-12-17       Impact factor: 3.511

Review 3.  Current management strategies for the pain of elderly patients with burning mouth syndrome: a critical review.

Authors:  Trang T H Tu; Miho Takenoshita; Hirofumi Matsuoka; Takeshi Watanabe; Takayuki Suga; Yuma Aota; Yoshihiro Abiko; Akira Toyofuku
Journal:  Biopsychosoc Med       Date:  2019-01-31

4.  Differences in the Clinical Characteristics of Persistent Idiopathic Facial Pain (Atypical Odontalgia) Patients with or Without Neurovascular Compression of the Trigeminal Nerve.

Authors:  Kaoru Kawasaki; Shiori Sugawara; Kazuya Watanabe; Chaoli Hong; Trang Thi Huyen Tu; Takeshi Watanabe; Junichiro Sakamoto; Norio Yoshino; Takayuki Suga; Lou Mikuzuki; Miho Takenoshita; Satoshi Takada; Tohru Kurabayashi; Akira Toyofuku
Journal:  Pain Med       Date:  2020-04-01       Impact factor: 3.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.